Four details:
1. Pacira’s bupivacaine liposome injectable suspension product is used in a variety of procedures, including orthopedic and spine surgeries.
2. The FDA approved Exparel for adults in 2011 and now will allow surgeons to use the product for pediatric patients ages 6 years and older.
3. Exparel is the first long-acting local anesthetic approved for pediatric use. The approval is based on a phase 3 study of Exparel in pediatric patients undergoing spine and cardiac procedures, which found no safety concerns.
4. More than 8 million patients have received Exparel for nonopioid pain control.
More articles on anesthetics:
How incorrectly documenting your anesthesia service can cost you your reimbursement
7 anesthesia company notes so far in 2021
Anesthesia market to hit $2.4B by 2025, market report says
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.